Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is one of the pathogens that urgently needs new drugs and new alternatives for its control. The primary strategy to combat this bacterium is combining treatments of beta-lactam with a beta-lactamase inhibitor. The most used combinations against P. a...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras-Gómez, María José, Martinez, José R. W., Rivas, Lina, Riquelme-Neira, Roberto, Ugalde, Juan A., Wozniak, Aniela, García, Patricia, Munita, José M., Olivares-Pacheco, Jorge, Alcalde-Rico, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574371/
https://www.ncbi.nlm.nih.gov/pubmed/36263116
http://dx.doi.org/10.3389/fphar.2022.1007162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574371/
https://www.ncbi.nlm.nih.gov/pubmed/36263116
http://dx.doi.org/10.3389/fphar.2022.1007162

Ejemplares similares